Celularity Historical Income Statement

CELUW Stock

USD 0.02 0 20.38%

Historical analysis of Celularity income statement accounts such as Interest Expense of 2.5 M, Selling General Administrative of 48.1 M or Selling And Marketing Expenses of 139.4 K can show how well Celularity performed in making a profits. Evaluating Celularity income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Celularity's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Celularity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Celularity is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

About Celularity Income Statement Analysis

Celularity Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Celularity shareholders. The income statement also shows Celularity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Celularity Income Statement Chart

At this time, Celularity's Depreciation And Amortization is fairly stable compared to the past year. EBIT is likely to climb to about 17.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.

Selling General Administrative Selling And Marketing Expenses Gross Profit Other Operating Expenses

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Celularity minus its cost of goods sold. It is profit before Celularity operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Celularity. It is also known as Celularity overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Celularity's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.At this time, Celularity's Depreciation And Amortization is fairly stable compared to the past year. EBIT is likely to climb to about 17.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.

	2021	2023	2024 (projected)
Interest Expense	3.2M	3.0M	2.5M
Depreciation And Amortization	51.1M	10.8M	20.6M

Interest Expense Depreciation And Amortization

Celularity income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Non Operating Income Net Other	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.38	0.7	-0.6	0.1	-0.21	0.61	-0.86	-0.5	-0.46	0.71	-0.31	0.25	0.7	-0.4	-0.58	0.07	-0.4	-0.08	0.65	-0.38	-0.54	0.43
Interest Expense	-0.38		-0.74	0.77	0.53	0.68	-0.75	0.76	0.72	0.5	-0.23	0.48	-0.44	-0.78	0.91	0.89	0.67	0.91	0.76	-0.62	0.14	0.66	-0.66
Selling General Administrative	0.7	-0.74		-0.97	-0.22	-0.83	0.97	-0.85	-0.66	-0.3	0.63	-0.2	0.79	0.99	-0.62	-0.95	-0.26	-0.63	-0.33	0.94	0.07	-0.65	0.83
Selling And Marketing Expenses	-0.6	0.77	-0.97		0.12	0.86	-0.97	0.8	0.78	0.14	-0.44	0.05	-0.85	-0.95	0.69	0.93	0.45	0.69	0.28	-0.97	0.0	0.77	-0.93
Total Revenue	0.1	0.53	-0.22	0.12		0.38	-0.19	0.17	-0.18	0.67	-0.33	0.74	0.02	-0.31	0.29	0.43	0.01	0.28	0.87	0.08	-0.44	-0.26	0.06
Gross Profit	-0.21	0.68	-0.83	0.86	0.38		-0.83	0.46	0.44	0.01	-0.42	-0.02	-0.91	-0.83	0.45	0.83	0.32	0.45	0.33	-0.8	-0.47	0.47	-0.84
Other Operating Expenses	0.61	-0.75	0.97	-0.97	-0.19	-0.83		-0.83	-0.73	-0.26	0.47	-0.18	0.82	0.96	-0.7	-0.95	-0.4	-0.7	-0.36	0.93	0.02	-0.65	0.83
Operating Income	-0.86	0.76	-0.85	0.8	0.17	0.46	-0.83		0.76	0.6	-0.51	0.49	-0.39	-0.86	0.79	0.86	0.35	0.79	0.47	-0.75	0.4	0.68	-0.59
Net Income From Continuing Ops	-0.5	0.72	-0.66	0.78	-0.18	0.44	-0.73	0.76		0.09	0.07	0.03	-0.49	-0.63	0.87	0.69	0.8	0.87	0.23	-0.74	0.57	0.92	-0.75
Ebit	-0.46	0.5	-0.3	0.14	0.67	0.01	-0.26	0.6	0.09		-0.45	0.99	0.28	-0.38	0.48	0.45	-0.03	0.47	0.8	0.01	0.2	-0.07	0.18
Research Development	0.71	-0.23	0.63	-0.44	-0.33	-0.42	0.47	-0.51	0.07	-0.45		-0.34	0.33	0.66	0.02	-0.51	0.53	0.02	-0.14	0.47	0.34	-0.05	0.27
Ebitda	-0.31	0.48	-0.2	0.05	0.74	-0.02	-0.18	0.49	0.03	0.99	-0.34		0.34	-0.28	0.46	0.39	0.01	0.45	0.86	0.12	0.16	-0.15	0.25
Cost Of Revenue	0.25	-0.44	0.79	-0.85	0.02	-0.91	0.82	-0.39	-0.49	0.28	0.33	0.34		0.75	-0.31	-0.69	-0.27	-0.32	0.03	0.88	0.38	-0.53	0.89
Total Operating Expenses	0.7	-0.78	0.99	-0.95	-0.31	-0.83	0.96	-0.86	-0.63	-0.38	0.66	-0.28	0.75		-0.64	-0.97	-0.26	-0.64	-0.41	0.9	0.08	-0.62	0.8
Income Before Tax	-0.4	0.91	-0.62	0.69	0.29	0.45	-0.7	0.79	0.87	0.48	0.02	0.46	-0.31	-0.64		0.78	0.82	1.0	0.68	-0.55	0.47	0.71	-0.56
Non Operating Income Net Other	-0.58	0.89	-0.95	0.93	0.43	0.83	-0.95	0.86	0.69	0.45	-0.51	0.39	-0.69	-0.97	0.78		0.43	0.78	0.59	-0.84	-0.03	0.62	-0.77
Total Other Income Expense Net	0.07	0.67	-0.26	0.45	0.01	0.32	-0.4	0.35	0.8	-0.03	0.53	0.01	-0.27	-0.26	0.82	0.43		0.82	0.38	-0.35	0.46	0.68	-0.51
Net Income	-0.4	0.91	-0.63	0.69	0.28	0.45	-0.7	0.79	0.87	0.47	0.02	0.45	-0.32	-0.64	1.0	0.78	0.82		0.67	-0.56	0.47	0.72	-0.57
Income Tax Expense	-0.08	0.76	-0.33	0.28	0.87	0.33	-0.36	0.47	0.23	0.8	-0.14	0.86	0.03	-0.41	0.68	0.59	0.38	0.67		-0.05	0.0	0.04	-0.05
Tax Provision	0.65	-0.62	0.94	-0.97	0.08	-0.8	0.93	-0.75	-0.74	0.01	0.47	0.12	0.88	0.9	-0.55	-0.84	-0.35	-0.56	-0.05		-0.01	-0.78	0.94
Net Interest Income	-0.38	0.14	0.07	0.0	-0.44	-0.47	0.02	0.4	0.57	0.2	0.34	0.16	0.38	0.08	0.47	-0.03	0.46	0.47	0.0	-0.01		0.48	0.04
Interest Income	-0.54	0.66	-0.65	0.77	-0.26	0.47	-0.65	0.68	0.92	-0.07	-0.05	-0.15	-0.53	-0.62	0.71	0.62	0.68	0.72	0.04	-0.78	0.48		-0.85
Reconciled Depreciation	0.43	-0.66	0.83	-0.93	0.06	-0.84	0.83	-0.59	-0.75	0.18	0.27	0.25	0.89	0.8	-0.56	-0.77	-0.51	-0.57	-0.05	0.94	0.04	-0.85

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Historical Income Statement

About Celularity Income Statement Analysis

Celularity Income Statement Chart

Gross Profit

Other Operating Expenses

Celularity income statement Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Total Operating Expenses	+ 0.99	Selling General Administrative
Ebitda	+ 0.99	Ebit
Other Operating Expenses	+ 0.97	Selling General Administrative
Total Operating Expenses	+ 0.96	Other Operating Expenses
Tax Provision	+ 0.94	Selling General Administrative

Non Operating Income Net Other	- 0.97	Total Operating Expenses
Tax Provision	- 0.97	Selling And Marketing Expenses
Other Operating Expenses	- 0.97	Selling And Marketing Expenses
Selling And Marketing Expenses	- 0.97	Selling General Administrative
Non Operating Income Net Other	- 0.95	Other Operating Expenses
Total Operating Expenses	- 0.95	Selling And Marketing Expenses